Japanese pharma company goes Nordic  

Large Japanese pharma merger means business for the Nordic region
This April two of the Japan’s largest pharma companies merged and into the new company Astellas. The company is now moving the Nordic headquarters to Copenhagen with plans to expand.
As a fusion of Yamanouchi and Fujisawa, Astellas is Japan’s second largest pharma company with an expected 2005 turnover of DKKK 45 bn. and 3000 employees in Europe alone.
Nordic Director, Mats Persson comments on the choice of Copenhagen: ‘Copenhagen’s geographical location is excellent for a Nordic headquarters. And furthermore we feel that it is very positive with the dynamics within pharma and biotech in the area surrounding Copenhagen and southern Sweden. The entire concept of Medicon Valley is another and very important reason for choosing Copenhagen.
The news was first reported in Jyllands Posten

Next step

Explore business cases

Please contact me

How can we help you?

We use cookies to make the website perform optimally. You accept cookies by closing the box or continuing to use the website. Click here to read more about cookies. ×